Jordan Manek Chinai, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunoglobulins | 5 | 2021 | 881 | 0.560 |
Why?
|
Virus Diseases | 1 | 2015 | 710 | 0.340 |
Why?
|
Imidazoles | 1 | 2011 | 1207 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 4 | 2016 | 1029 | 0.230 |
Why?
|
Immunotherapy | 3 | 2016 | 4391 | 0.230 |
Why?
|
Antiviral Agents | 1 | 2015 | 2971 | 0.220 |
Why?
|
Receptors, KIR | 1 | 2021 | 113 | 0.200 |
Why?
|
Antibodies, Monoclonal | 4 | 2021 | 9259 | 0.190 |
Why?
|
Osteosarcoma | 2 | 2016 | 884 | 0.190 |
Why?
|
Insulin | 1 | 2011 | 6569 | 0.140 |
Why?
|
Genes, erbB-1 | 1 | 2016 | 161 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 4424 | 0.120 |
Why?
|
Neoplasms | 3 | 2021 | 21507 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13635 | 0.100 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2011 | 74 | 0.100 |
Why?
|
Hybridomas | 1 | 2011 | 452 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 969 | 0.090 |
Why?
|
Phenylalanine | 1 | 2011 | 365 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2016 | 3508 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1798 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6397 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2016 | 2728 | 0.060 |
Why?
|
Models, Molecular | 2 | 2014 | 5460 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1431 | 0.060 |
Why?
|
Killer Cells, Natural | 3 | 2021 | 2133 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2521 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3694 | 0.060 |
Why?
|
Protein Conformation | 1 | 2011 | 4012 | 0.060 |
Why?
|
Protein Binding | 2 | 2014 | 9375 | 0.050 |
Why?
|
3T3 Cells | 2 | 2014 | 1103 | 0.050 |
Why?
|
Binding Sites | 1 | 2011 | 6113 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4374 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6318 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5154 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 2897 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16646 | 0.040 |
Why?
|
Cell Survival | 2 | 2021 | 5877 | 0.040 |
Why?
|
Carcinoma, Large Cell | 1 | 2016 | 113 | 0.030 |
Why?
|
Animals | 6 | 2021 | 168368 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 552 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 411 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5147 | 0.030 |
Why?
|
Surface Plasmon Resonance | 1 | 2014 | 275 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2014 | 312 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 301 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2021 | 2256 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2016 | 12985 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2014 | 13816 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2021 | 19220 | 0.030 |
Why?
|
Glycosylation | 1 | 2014 | 1125 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18125 | 0.020 |
Why?
|
Humans | 10 | 2021 | 739398 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2013 | 853 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 2015 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2013 | 2833 | 0.020 |
Why?
|
Mice | 4 | 2021 | 81002 | 0.020 |
Why?
|
Cytoplasm | 1 | 2013 | 1536 | 0.020 |
Why?
|
Epitopes | 1 | 2014 | 2558 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3848 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1967 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1991 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1820 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 1936 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6871 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 28901 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6516 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2208 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2359 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2013 | 1936 | 0.020 |
Why?
|
Cell Membrane | 1 | 2013 | 3747 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 5959 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4174 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7788 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5631 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10247 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4014 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8400 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9387 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4663 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10455 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7298 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10142 | 0.010 |
Why?
|
Female | 4 | 2016 | 378853 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18003 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9714 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29658 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 212863 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56255 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20676 | 0.010 |
Why?
|
Male | 2 | 2016 | 349022 | 0.010 |
Why?
|
Child | 1 | 2016 | 77033 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 85405 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2016 | 76631 | 0.000 |
Why?
|
Aged | 1 | 2016 | 162698 | 0.000 |
Why?
|
Adult | 1 | 2016 | 213394 | 0.000 |
Why?
|